FREEMAN ROGER K 4
4 · MEDNAX, INC. · Filed Nov 9, 2012
Insider Transaction Report
Form 4
FREEMAN ROGER K
Director
Transactions
- Exercise/Conversion
Common Stock
2012-11-08$37.82/sh+8,792$332,513→ 11,217 total - Sale
Common Stock
2012-11-08$75.81/sh−8,792$666,528→ 2,425 total - Exercise/Conversion
Stock Options (Right to Buy)
2012-11-08$50.34/sh−5,334$268,514→ 0 totalExercise: $50.34From: 2009-05-04Exp: 2016-05-04→ Common Stock (5,334 underlying) - Exercise/Conversion
Common Stock
2012-11-08$50.34/sh+5,334$268,514→ 7,759 total - Sale
Common Stock
2012-11-08$75.81/sh−5,334$404,374→ 2,425 total - Sale
Common Stock
2012-11-08$75.68/sh−800$60,546→ 1,625 total - Exercise/Conversion
Stock Options (Right to Buy)
2012-11-08$37.82/sh−8,792$332,513→ 0 totalExercise: $37.82From: 2012-05-06Exp: 2019-05-06→ Common Stock (8,792 underlying)
Footnotes (2)
- [F1]Sales of shares were executed in thirty-six (36) separate transactions with prices ranging from $75.63 to $75.96 for a weighted average sales price of $75.8107.
- [F2]Sales of shares were executed in four (4) separate transactions with prices ranging from $75.68 to $75.681 for a weighted average sales price of $75.6831.